(BBRE) JPMorgan BetaBuilders MSCI - Ratings and Ratios
REITs, Real Estate, US, Equity, Futures
Description: BBRE JPMorgan BetaBuilders MSCI
JPMorgan BetaBuilders MSCI US REIT ETF (BATS:BBRE) is an exchange-traded fund that tracks the performance of the MSCI US REIT Index, providing investors with exposure to the US real estate investment trust (REIT) market. The funds investment strategy is to replicate the underlying index, which is a market-capitalization-weighted index that includes a diverse range of US REIT securities.
The funds portfolio is comprised of at least 80% of its assets in securities that are part of the underlying index, ensuring that its performance closely mirrors that of the US REIT market. Additionally, the fund may invest up to 20% of its assets in exchange-traded futures to enhance its performance and maintain its tracking efficiency.
With an AUM of $907.70 million, BBRE has established itself as a significant player in the US REIT ETF market. Its market-capitalization-weighted approach ensures that the fund is tilted towards the largest and most liquid REIT securities, providing investors with a stable and diversified exposure to the US real estate market.
From a technical analysis perspective, BBREs recent price action has been positive, with its 20-day SMA at $93.09 and 50-day SMA at $91.73, indicating a bullish trend. The funds current price of $93.29 is above its 20-day SMA, suggesting a continuation of the upward momentum. However, its 200-day SMA at $94.81 may pose a resistance level, potentially capping the funds upside in the short term.
Using a combination of technical and fundamental analysis, a forecast for BBRE can be made. Given the funds tracking efficiency and the overall trend in the US REIT market, it is likely that BBRE will continue to perform in line with its underlying index. With the 52-week high and low at $101.30 and $82.14, respectively, and an ATR of 1.05 (1.13%), the funds price is expected to remain volatile in the short term. However, its long-term prospects appear positive, driven by the steady demand for US REIT securities and the funds diversified portfolio. As such, a potential target price for BBRE could be around $100, representing a 7% upside from its current price.
BBRE ETF Overview
| Market Cap in USD | 911m |
| Category | Real Estate |
| TER | 0.11% |
| IPO / Inception | 2018-06-15 |
BBRE ETF Ratings
| Growth Rating | 17.1 |
| Fundamental | 45.0% |
| Dividend Rating | 51.7 |
| Rel. Strength | -2.47 |
| Analysts | - |
| Fair Price Momentum | 87.45 USD |
| Fair Price DCF | - |
BBRE Dividends
| Dividend Yield 12m | 3.14% |
| Yield on Cost 5y | 4.43% |
| Annual Growth 5y | 3.50% |
| Payout Consistency | 94.7% |
| Payout Ratio | % |
BBRE Growth Ratios
| Growth Correlation 3m | 6.7% |
| Growth Correlation 12m | -57.4% |
| Growth Correlation 5y | 47.4% |
| CAGR 5y | 6.86% |
| CAGR/Max DD 5y | 0.22 |
| Sharpe Ratio 12m | 0.83 |
| Alpha | -14.38 |
| Beta | 0.584 |
| Volatility | 19.00% |
| Current Volume | 3k |
| Average Volume 20d | 5.9k |
| Stop Loss | 88.3 (-3%) |
As of August 10, 2025, the stock is trading at USD 91.03 with a total of 3,000 shares traded.
Over the past week, the price has changed by +0.28%, over one month by -1.13%, over three months by -0.13% and over the past year by -0.04%.
No, based on ValueRay´s Fundamental Analyses, JPMorgan BetaBuilders MSCI (BATS:BBRE) is currently (August 2025) a stock to sell. It has a ValueRay Fundamental Rating of 45.00 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BBRE is around 87.45 USD . This means that BBRE is currently overvalued and has a potential downside of -3.93%.
JPMorgan BetaBuilders MSCI has no consensus analysts rating.
According to our own proprietary Forecast Model, BBRE JPMorgan BetaBuilders MSCI will be worth about 96.4 in August 2026. The stock is currently trading at 91.03. This means that the stock has a potential upside of +5.88%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 96.4 | 5.9% |
ValueRay Score 45.00
| 1. Piotroski 0.0pt = -5.0 |
BBRE Fundamental Data Overview
[93m CCE Cash And Equivalents = unknown
[39m[93m Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
[39m Beta = 1.16
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
[93m Long Term Debt = unknown (none)
[39m[93m Short Term Debt = unknown (none)
[39m[93m Debt = unknown
[39m[93m Net Debt = unknown
[39m Enterprise Value = 910.6m USD (910.6m + (null Debt) - (null CCE))
[93m Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
[39m[93m FCF Yield = none (FCF TTM 0.0 / Enterprise Value 910.6m)
[39m[93m FCF Margin = unknown (Revenue TTM is 0)
[39m[93m Net Margin = unknown
[39m[93m Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
[39m[93m Tobins Q-Ratio = unknown (Enterprise Value 910.6m / Book Value Of Equity 0.0)
[39m Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
[93m Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
[39m[93m Debt / Equity = unknown Debt (none)
[39m[93m Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
[39m[93m Debt / FCF = none (Debt none / FCF TTM 0.0)
[39m[93m Total Stockholder Equity = unknown
[39m[93m RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
[39m[93m RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
[39m[93m RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
[39m[93m WACC = unknown (E(910.6m)/V(0.0) * Re(8.17%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
[39m Discount Rate = 8.17% (= CAPM, Blume Beta Adj.)
[93m Fair Price DCF = unknown (Cash Flow 0.0)
[39m
Additional Sources for BBRE ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle